Hyqvia Approved for Chronic Inflammatory Demyelinating Polyneuropathy

The FDA has approved Hyqvia (immune globulin infusion 10% [human] with recombinant human hyaluronidase) for chronic inflammatory demyelinating polyneuropathy.

Related Keywords

,Drug Administration ,Rasch Built Overall Disability Scale ,